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Intra-articular metallic gold micro particles relieve pain 
and enhance function in patients with knee osteoarthritis
Conclusions
Intra-articular metallic gold improved joint pain, stiffness and function. The increased pressure 
pain threshold indicate less joint hyperalgesia. Intra articular gold particles may modify the syn-
ovial inflammation as a part of the sensitization in knee OA patients. In this cohort of patients 
with moderate to severe knee osteoarthritis and synovial effusion intra-articular metallic gold 
relieved pain and enhanced function in more than 80 % of the patients. This study suggests a 
basis for a future placebo controlled randomized trial in OA patients.
Aim of Investigations
Many patients suffering from osteoarthritis (OA) do not get 
adequate pain relieve. Current therapies relieve pain to some 
extent and up to 30 % having an arthroplasty do not achieve 
sufficient improvement.
Animal studies indicate gold ions have a long-acting effect on 
OA pain. The immuno-modulatory effect of gold ions have for 
more than 50 years a known anti-inflammatory effect in the 
treatment of rheumatic arthritis. Gold ions alter the function 
of macrophages by inhibiting lysosomal enzymes and lowering 
production of pro-inflammatory cytokines(1-2).
Dissolucytotic metallic gold (DMG) ions have an immune-sup-
pressive effect in laboratory testing(3-5) (Figure 1-3). Animal stud-
ies prove the effect of gold implantation in arthritic joints(6-9). 
Injection of DMG in animal models stimulate the immune sys-
tem(10-11). The carrier for injecting the DMG micro particles is 
hyaluronic acid (12-13).
No studies have investigated the effect of intraarticular gold mi-
cro particle implants for treatment of knee osteoarthritis in hu-
mans. The present open, pilot study aimed to investigate if gold 
ions have a role in treating knee osteoarthritis(14).
Methods
A cohort of 30 patients referred for treatment of knee OA, aged 
≥18years, pain ≥ 3 months, synovial effusion on MRI, and Kell-
gren-Lawrence OA grade 3-4 were included. Exclusion criteria 
were malignancy, active infection and antibiotic treatment, ac-
tive treatment with steroids, biological or other anti-Rheumatic 
medication, inability to comply with the protocol, inadequacy 
in written and spoken national language. Of 38 eligible patients, 
32 met the criteria, 1 did not attend and 1 refused. Age was 63 
(46-75) year, BMI 28.8 (22.8-41.7), 18 were men 12 women.
Metallic gold 20 mg, 72.000 pieces, 20-40 my-meter in diam-
eter (Berlock-Micro-Implants, BMI, Goldtreat APS) (12-13) were 
injected into the knee joint using the patient’s own synovial flu-
id as the carrier. Outcome measures were WOMAC pain, stiff-
ness and function, PainDetect questionnaire, and Quantitative 
Sensory Testing (QST) (pressure pain threshold assessed over 
the knee joint) at inclusion and after 8 weeks.
Results
Pain and function improved in 25 of 30 patients. Womac pain 
decreased from 9 (6-16) to 3 (0-15), stiffness from 4 (1-8) to 2 
(0-8), function from 29 (14-51) to 11 (0-41) (Figure 4), Pain-
Detect decreased from 10 (1-26) to 3 (0-19) (Figure 5). Pain 
pressure thresholds increased (anti-hyperalgesia) from 598 kPa 
(276-1043) to 616 kPa (349-1089) (Figure 6). All differences, 
P < 0.05 (Wilcoxon sign test).
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Figure 1: Macrophages controls the dissolution membrane which liberate 
the gold ions by oxidation of the surface. Once the ions are liberated, most 
likely as Dicyanogold [Au(CN)2]-, they are free to diffuse through the imme-
diate microenvironment. The gold-loaded molecules are taken up into the 
cells, primarily  macrophages, mastcells and histocytes. 
Figure 2: Close to the gold implant gold-loaded molecular clusters are lo-
cated outside cells. The two loaded cells are believed to be macrophages 
loaded with gold ions. The gold ions accumulate primarily in the lysosymes. 
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Figure 3: Once in the intercellular fluid and the intracellular compartments, 
i.e. lysosomes, the gold ions act in the same ways that have been demon-
strated for systemically administered gold ions. Gold ions suppress inflam-
mation locally probably partly by affecting certain signalling molecules and 
binding enzymes essential for the inflammatory process. The reduced pro-
duction of pro-inflammatory cytokines might relate to the ability of the gold 
ions to unfold the protein structures.
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